Asset Details
Do you wish to reserve the book?
Mid-term outcomes of endoscopic vein harvesting in coronary artery bypass grafting: a retrospective cohort study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mid-term outcomes of endoscopic vein harvesting in coronary artery bypass grafting: a retrospective cohort study
Do you wish to request the book?
Mid-term outcomes of endoscopic vein harvesting in coronary artery bypass grafting: a retrospective cohort study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mid-term outcomes of endoscopic vein harvesting in coronary artery bypass grafting: a retrospective cohort study
2024
Overview
Objectives
Endoscopic vein harvesting (EVH) is an alternative technique to obtain the saphenous vein for coronary artery bypass grafting (CABG) surgery. We aimed to evaluate the early and mid-term outcomes of patients with EVH in CABG.
Methods
This cohort study included consecutive isolated CABG patients in Nanjing First Hospital from July 2020 to December 2022 using propensity score matching methods. Patients were classified to EVH group and open vein harvesting (OVH) group according to the vein harvesting methods. The primary outcome was the all-cause death, and the secondary outcomes were major adverse cardiovascular events (MACEs) including cardiovascular death, heart failure, myocardial infarction and revascularization and asymptomatic survival in the follow-up.
Results
Totally 1247 patients were included in the study with 849 in OVH group and 398 in EVH group. Patients with EVH were more female, diabetes, higher body mass index, more multi-vessel and left main diseases. 308 pairs were formed after the matching. There was no significant difference in the rates of in-hospital death (EVH vs. OVH, 2.3% vs. 1.3%,
P
= 0.543). During the 3 years follow-up, EVH grafts were considered not inferior to OVH grafts, no differences were found in all-cause death [8.5% vs. 5.0%, hazard ratio (HR) 1.565, 95% confidence interval (CI): 0.77–3.17,
P
= 0.21], MACEs (8.1% vs. 7.1%, HR 1.165, 95CI: 0.51–2.69,
P
= 0.71) and asymptomatic survival (66.7% vs. 72.5%, HR 1.117, 95%CI: 0.65–1.92,
P
= 0.68).
Conclusions
EVH grafts were considered comparable to OVH grafts in patients following CABG in the 3 years follow-up.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Analysis
/ Bypass
/ Coronary Artery Bypass - methods
/ Coronary Artery Bypass - mortality
/ Coronary artery bypass grafting
/ Coronary Artery Disease - surgery
/ Death
/ Female
/ Grafting
/ Humans
/ Male
/ Matching
/ Medicine
/ Patients
/ Saphenous Vein - transplantation
/ Surgery
/ Survival
/ Tissue and Organ Harvesting - methods
/ Veins
